Your session is about to expire
← Back to Search
Regenerative Medicine
Cell Therapy for Knee Osteoarthritis
Phase 2
Recruiting
Led By Mark LoDico, MD
Research Sponsored by VivaTech International, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients with adequate renal function, Creatinine ≤ 1.5 mg/dl
Patients with indication of Osteoarthritis, grade 2 or more from degeneration or chronic injury
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 0 and (6 - 12 months optional)
Awards & highlights
Study Summary
This trial tests if a therapy using the patient's own cells helps knee osteoarthritis pain & inflammation. 50 patients tested, then 4,000 more.
Who is the study for?
This trial is for adults aged 18-90 with knee pain from osteoarthritis (grade 2 or higher) for over 6 months. Participants should have good immune, kidney, blood coagulation, heart and lung function. Excluded are those with recent steroid injections or strokes, heavy NSAID use before the procedure, certain cancers within 5 years, severe obesity (BMI >40), infections including hepatitis B/C or HIV, gout conditions and strong opioid use recently.Check my eligibility
What is being tested?
The study tests the safety and effectiveness of autologous cell therapy using StroMed combined with platelet rich plasma (PRP) versus PRP alone in reducing knee pain and inflammation due to osteoarthritis. It's an open-label trial starting with 50 patients followed by a larger group of up to 4,000 participants.See study design
What are the potential side effects?
While specific side effects aren't listed here, similar therapies may cause injection site reactions like pain or swelling; risk of infection; allergic reactions; temporary increase in inflammation; bleeding due to blood thinning effect of PRP.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My kidney function is good, with creatinine levels at or below 1.5 mg/dl.
Select...
I have moderate to severe osteoarthritis.
Select...
I have had knee pain for more than 6 months.
Select...
My immune system is healthy and I don't have an immunodeficiency disease.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 0 and (6 - 12 months optional)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~0 and (6 - 12 months optional)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change is being assessed for the KOOS survey (Knee Osteoarthritis Outcome Score)
Secondary outcome measures
Change is being assessed by MRI of afflicted joint
Change is being assessed for the NRS survey (Numerical Rating Scale for Pain)
Change is being assessed for the SF36 survey (Short Form Health Survey)
Trial Design
2Treatment groups
Experimental Treatment
Group I: Cohort 2Experimental Treatment2 Interventions
Interventions assigned by Principal Investigator
Group II: Cohort 1Experimental Treatment2 Interventions
Interventions assigned by Principal Investigator
Find a Location
Who is running the clinical trial?
VivaTech International, Inc.Lead Sponsor
2 Previous Clinical Trials
8,000 Total Patients Enrolled
2 Trials studying Osteoarthritis
8,000 Patients Enrolled for Osteoarthritis
Mark LoDico, MDPrincipal InvestigatorAdvanced Regenerative Medicine
2 Previous Clinical Trials
8,000 Total Patients Enrolled
2 Trials studying Osteoarthritis
8,000 Patients Enrolled for Osteoarthritis
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have moderate to severe osteoarthritis.I have had knee pain for more than 6 months.I had a mini-stroke within the last 6 months.I am between 18 and 90 years old.My kidney function is good, with creatinine levels at or below 1.5 mg/dl.My heart and lungs are working well.My kidney function is good, with creatinine levels at or below 1.5 mg/dl.My heart and lungs are working well.I haven't had cancer in the last 5 years, except for skin cancer that was removed.My immune system is healthy and I don't have an immunodeficiency disease.I have moderate to severe osteoarthritis.I have had knee pain for more than 6 months.I don't have other health issues or recent treatments that could affect pain or mobility assessments.I am between 18 and 90 years old.I am infected with hepatitis B, C, or HIV.I have a serious heart or stroke condition.I currently have an active infection.My immune system is healthy and I don't have an immunodeficiency disease.
Research Study Groups:
This trial has the following groups:- Group 1: Cohort 2
- Group 2: Cohort 1
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Who else is applying?
What site did they apply to?
VivaTech International, Inc.
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
Why did patients apply to this trial?
I have osteoarthritis in my left knee. I’m hoping this clinical trial will help resolve right knee pain.
PatientReceived no prior treatments
Share this study with friends
Copy Link
Messenger